Neonatal diabetes

Gene: EIF2B1

Green List (high evidence)

EIF2B1 (eukaryotic translation initiation factor 2B subunit alpha)
EnsemblGeneIds (GRCh38): ENSG00000111361
EnsemblGeneIds (GRCh37): ENSG00000111361
OMIM: 606686, Gene2Phenotype
EIF2B1 is in 11 panels

2 reviews

Arina Puzriakova (Genomics England Curator)

Green List (high evidence)

The rating of this gene has been updated to Green and the mode of inheritance set to 'MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown' following NHS Genomic Medicine Service approval.
Created: 31 Jan 2023, 4:43 p.m. | Last Modified: 31 Jan 2023, 4:43 p.m.
Panel Version: 3.3

Eleanor Williams (Genomics England Curator)

Comment on list classification: Promoting to amber, but with a recommendation for green status.
Created: 27 Sep 2022, 1:49 p.m. | Last Modified: 27 Sep 2022, 1:49 p.m.
Panel Version: 2.49
Associated with Leukoencephalopathy with vanishing white matter, #603896 (AR) in OMIM.

As expert reviewer reports De Franco et al 2020 (PMID:31882561) screened patients with Permanent neonatal diabetes (PNDM) and early onset diabetes using a targeted next generation sequencing assay, including the known monogenic diabetes genes and additional candidate genes, such as EIF2B1. 5 de novo EIF2B1 variants were identified, p.(Gly44Asp), p.(Gly44Val), p.(Ser77Asn), p.(Leu34Trp), p.(*306Thrext*12). Onset of diabetes was at 21 weeks or less in 4 patients, and at 56 weeks in the 5th. The patients do not exhibit severe neurological features seen in cases with homozygous variants in EIF2B1 but two reported cases displayed mild learning disability or attention deficit disorder.
Created: 27 Sep 2022, 1:48 p.m. | Last Modified: 27 Sep 2022, 11:40 p.m.
Panel Version: 2.57
Review on behalf of Jayne Houghton and Kevin Colclough, Exeter Genomics Laboratory, SWGLH. Trio whole genome sequencing in patients with permanent neonatal diabetes and their parents for whom all the known genetic causes for neonatal diabetes had been excluded identified de novo variants in the EIF2B1 gene. To date there are 5 reported cases (De Franco et al 2020 Diabetes; PMID: 31882561). The patients presented with diabetes between the ages of 4 and 56 weeks and were treated with full insulin replacement doses. The 4 patients for whom data was available had low birth weight (<20th centile, SDS range -0.84- -1.74) consistent with reduced insulin secretion in utero. The variants, 4 missense and one stop-loss, are all predicted to map to the same protein surface and in silico modelling suggests that they are likely to disrupt the interaction of the EIF2Ba subunit (encoded by EIF2B1) with phosphorylated EIF2a during the cell Integrated Stress Response. These patients clinical features are markedly different from those reported in patients with leukoencephalopathy with vanishing white matter (VWM), a rare paediatric neurological disease caused by recessive loss-of-function EIF2B1 mutations. VWM is a progressive condition usually fatal in childhood. Extra-neurological features are generally not present. None of the 5 patients reported by De Franco et al had severe neurological features. The heterozygous carrier parents of VWM patients are clinically unaffected supporting the hypothesis that the variants identified in patients presenting with neonatal diabetes do not result in complete loss of function of the eIF2B complex.
Created: 14 Sep 2022, 4:42 p.m. | Last Modified: 14 Sep 2022, 4:42 p.m.
Panel Version: 2.40

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
Permanent neonatal/early onset diabetes and transient liver dysfunction.

Publications

History Filter Activity

31 Jan 2023, Gel status: 3

Removed Tag, Removed Tag

Arina Puzriakova (Genomics England Curator)

Tag Q3_22_rating was removed from gene: EIF2B1. Tag Q3_22_NHS_review was removed from gene: EIF2B1.

31 Jan 2023, Gel status: 3

Added New Source, Added New Source, Status Update

Arina Puzriakova (Genomics England Curator)

Source Expert Review Green was added to EIF2B1. Source NHS GMS was added to EIF2B1. Rating Changed from Amber List (moderate evidence) to Green List (high evidence)

27 Sep 2022, Gel status: 2

Added Tag, Added Tag

Eleanor Williams (Genomics England Curator)

Tag Q3_22_rating tag was added to gene: EIF2B1. Tag Q3_22_NHS_review tag was added to gene: EIF2B1.

27 Sep 2022, Gel status: 2

Entity classified by Genomics England curator

Eleanor Williams (Genomics England Curator)

Gene: eif2b1 has been classified as Amber List (Moderate Evidence).

27 Sep 2022, Gel status: 1

Entity classified by Genomics England curator

Eleanor Williams (Genomics England Curator)

Gene: eif2b1 has been classified as Red List (Low Evidence).

27 Sep 2022, Gel status: 1

Set Phenotypes

Eleanor Williams (Genomics England Curator)

Phenotypes for gene: EIF2B1 were changed from to Permanent neonatal/early onset diabetes and transient liver dysfunction

27 Sep 2022, Gel status: 1

Set publications

Eleanor Williams (Genomics England Curator)

Publications for gene: EIF2B1 were set to

27 Sep 2022, Gel status: 1

Set mode of inheritance

Eleanor Williams (Genomics England Curator)

Mode of inheritance for gene: EIF2B1 was changed from to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

14 Sep 2022, Gel status: 1

Created, Added New Source, Set mode of inheritance

Eleanor Williams (Genomics England Curator)

gene: EIF2B1 was added gene: EIF2B1 was added to Diabetes - neonatal onset. Sources: Expert review Mode of inheritance for gene: EIF2B1 was set to